Braster SA
WSE:BRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (99.8), the stock would be worth zł0.58 (0% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 99.8 | zł0.58 |
0%
|
| 3-Year Average | 99.8 | zł0.58 |
0%
|
| 5-Year Average | 99.8 | zł0.58 |
0%
|
| Industry Average | 0.9 | zł0.01 |
-99%
|
| Country Average | 1.5 | zł0.01 |
-99%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| PL |
B
|
Braster SA
WSE:BRA
|
17m PLN | 99.8 | -4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 15.4 | 56.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 3.5 | 25 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 5.3 | 37.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 3.4 | 22.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 4.5 | 23.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 7 | 43.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 2 | 18.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 10.4 | 42.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 2.7 | 23.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 5.5 | 20.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.5 |
| 70th Percentile | 3.3 |
| Max | 491.2 |
Other Multiples
Braster SA
Glance View
Braster SA engages in the development and manufacturing of medical devices for self-examination. The firm provides research and development on breast cancer. The company applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The firm cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.
